Inovio Allies With the NCI and International AIDS Vaccine Initiative to Research Its DNA Delivery Tool

Inovio Biomedical reports that its wholly owned subsidiary, Genetronics, entered into separate deals with the NCI and International AIDS Vaccine Initiative (IAVI), to evaluate Inovio’s electroporation technology for the delivery of DNA vaccines. The technology is designed to enhance the potency of DNA-based immunotherapies and vaccines against infectious diseases and cancers.
Genetic Engineering and biotechnology News